Simon C. Pedder
Founder of Chelsea Therapeutics International Ltd., Simon C. Pedder is a businessperson who has been at the helm of 6 different companies is Chief Business & Strategy Officer at Athenex, Inc. and on the board of 5 other companies.
In the past he was President, Chief Executive Officer & Director at Cellectar BioSciences, Inc. and Chief Executive Officer & Director at Novelos Therapeutics, Inc. (a subsidiary of Cellectar BioSciences, Inc.), President & Chief Executive Officer at Chelsea Therapeutics, Inc., President & Chief Executive Officer at Chelsea Therapeutics International Ltd., President & Chief Executive Officer at Ivory Capital Corp., Vice President-Pharmaceutical Business & Oncology at Hoffmann-La Roche, Inc. and Vice President-Drug Development at Shearwater Corp.
Simon C. Pedder received an undergraduate degree from The University of Waterloo, a graduate degree from Concordia University and a doctorate from the University of Saskatchewan College of Medicine.
|08/27/2019||6,734||Acquisition at $2.98 per share.||20,067|
|05/24/2019||250,000||Award at $0 per share.||0|
|05/14/2019||6,000||Acquisition at $5.06 per share.||30,360|